Correlation Between Adhera Therapeutics and Scopus Biopharma
Can any of the company-specific risk be diversified away by investing in both Adhera Therapeutics and Scopus Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adhera Therapeutics and Scopus Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adhera Therapeutics and Scopus Biopharma, you can compare the effects of market volatilities on Adhera Therapeutics and Scopus Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adhera Therapeutics with a short position of Scopus Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adhera Therapeutics and Scopus Biopharma.
Diversification Opportunities for Adhera Therapeutics and Scopus Biopharma
0.3 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Adhera and Scopus is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Adhera Therapeutics and Scopus Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scopus Biopharma and Adhera Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adhera Therapeutics are associated (or correlated) with Scopus Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scopus Biopharma has no effect on the direction of Adhera Therapeutics i.e., Adhera Therapeutics and Scopus Biopharma go up and down completely randomly.
Pair Corralation between Adhera Therapeutics and Scopus Biopharma
If you would invest 10.00 in Scopus Biopharma on August 24, 2024 and sell it today you would earn a total of 0.00 from holding Scopus Biopharma or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Adhera Therapeutics vs. Scopus Biopharma
Performance |
| Timeline |
| Adhera Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Scopus Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Adhera Therapeutics and Scopus Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Adhera Therapeutics and Scopus Biopharma
The main advantage of trading using opposite Adhera Therapeutics and Scopus Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adhera Therapeutics position performs unexpectedly, Scopus Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scopus Biopharma will offset losses from the drop in Scopus Biopharma's long position.| Adhera Therapeutics vs. Enveric Biosciences | Adhera Therapeutics vs. Akeso, Inc | Adhera Therapeutics vs. Avax Techs | Adhera Therapeutics vs. Ascletis Pharma |
| Scopus Biopharma vs. Scpharmaceuticals | Scopus Biopharma vs. DiaMedica Therapeutics | Scopus Biopharma vs. Monopar Therapeutics | Scopus Biopharma vs. Pasithea Therapeutics Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |